| Mrs Reeta R Griffin, RPH | |
|
651 Highway 28 Byp, Anderson, SC 29624-3009 | |
| (864) 261-7453 | |
| (864) 261-7518 |
| Full Name | Mrs Reeta R Griffin |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 651 Highway 28 Byp, Anderson, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922357862 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 005394 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Reeta R Griffin, RPH 651 Highway 28 Byp, Anderson, SC 29624-3009 Ph: (864) 261-7453 | Mrs Reeta R Griffin, RPH 651 Highway 28 Byp, Anderson, SC 29624-3009 Ph: (864) 261-7453 |
News Archive
In this post on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Kent Campbell, director of the Malaria Control Program at PATH, says "dramatic gains" made in the fight against malaria, and the possibility of ending the disease, are in jeopardy because the "Global Fund to Fight AIDS, Tuberculosis and Malaria, which provides two-thirds of the global financing for efforts to combat malaria, is facing a financial crisis due to unfulfilled donor commitments."
A new study out of the Netherlands and published on the preprint server bioRxiv* in July 2020 discusses the commonly observed phenomenon of COVID-19 progression at 1-2 weeks from the onset of the earliest symptoms. This is ascribed to the overactivation of the inflammatory signaling cascade triggered by a hyperactive adaptive immune reaction, commonly called the cytokine storm.
Transparency Life Sciences, LLC (TLS), the world's first clinical-stage drug development company based on open innovation, today announced that it has received a Small Business Innovation Research (SBIR) program grant to fund a Phase 2a proof-of-concept study testing the utility of the ACE inhibitor lisinopril as an adjunctive therapy for multiple sclerosis (MS).
Stereotaxis, Inc. announced today that it had priced the public offering of 6,500,000 shares of its common at a price to the public of $4.00 per share. Stereotaxis has granted the underwriters of the offering an option to purchase up to an additional 975,000 shares of common stock to cover over-allotments, if any. All of the shares in the offering are being offered by Stereotaxis. Stereotaxis expects the offering to close on October 15, 2009.
DiscoveRx Corp. and BioFocus® announced today that they have signed a co-marketing agreement that allows BioFocus to perform screening on behalf of BioFocus' customers using DiscoveRx PathHunter™ ß-Arrestin GPCR screening assay, HitHunter™ cAMP assays and associated cell lines.
› Verified 9 days ago
Dr. Jennifer E Thompson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 864-512-1598 | |
Michael Earl Mcwhorter, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1405 E Greenville St, Anderson, SC 29621 Phone: 864-224-8797 Fax: 864-224-4996 | |
Charles Clinkscales, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 118 Parkside Dr, Anderson, SC 29621 Phone: 864-353-3198 | |
Paul Wilbur Fulbright Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2814 N. Main St, Anderson, SC 29621 Phone: 864-224-3562 | |
Ms. Marla Winstead Kinkle, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1704 E Greenville St, Anderson, SC 29621 Phone: 864-375-9401 Fax: 864-231-9358 | |
Walter Carr, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 864-512-2919 | |
Dr. Elizabeth Morash, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 109 Essex Dr, Anderson, SC 29621 Phone: 864-512-3428 Fax: 864-512-2093 |